Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
Genetics in Medicine Open
|
January 5, 2026
ApplyPolygenicScore: An R package for applying polygenic risk score models
Nicole Zeltser, Rachel M A Dang, Rupert Hugh-White, et al.
Nature Cell Biology
|
December 4, 2023
Prostate lineage-specific metabolism governs luminal differentiation and response to antiandrogen treatment
Jenna M Giafaglione, Preston D Crowell, Amelie M L Delcourt, et al.
Biorxiv : the Preprint Server for Biology
|
February 24, 2025
The Landscape of Prostate Tumour Methylation
Jaron Arbet, Takafumi N Yamaguchi, Yu-Jia Shiah, et al.
Cancer Discovery
|
June 17, 2026
The Landscape of Prostate Tumour Methylation
Jaron Arbet, Takafumi N Yamaguchi, Yu-Jia Shiah, et al.
Nature Medicine
|
July 21, 2025
Author Correction: Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial
Farshad Nassiri, Vikas Patil, Leeor S Yefet, et al.
Nature Medicine
|
May 15, 2023
Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial
Farshad Nassiri, Vikas Patil, Leeor S Yefet, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
Genetics in Medicine Open
|
January 5, 2026
ApplyPolygenicScore: An R package for applying polygenic risk score models
Nicole Zeltser, Rachel M A Dang, Rupert Hugh-White, et al.
Nature Cell Biology
|
December 4, 2023
Prostate lineage-specific metabolism governs luminal differentiation and response to antiandrogen treatment
Jenna M Giafaglione, Preston D Crowell, Amelie M L Delcourt, et al.
Biorxiv : the Preprint Server for Biology
|
February 24, 2025
The Landscape of Prostate Tumour Methylation
Jaron Arbet, Takafumi N Yamaguchi, Yu-Jia Shiah, et al.
Cancer Discovery
|
June 17, 2026
The Landscape of Prostate Tumour Methylation
Jaron Arbet, Takafumi N Yamaguchi, Yu-Jia Shiah, et al.
Nature Medicine
|
July 21, 2025
Author Correction: Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial
Farshad Nassiri, Vikas Patil, Leeor S Yefet, et al.
Nature Medicine
|
May 15, 2023
Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial
Farshad Nassiri, Vikas Patil, Leeor S Yefet, et al.
Page
of 1